Open Label Assessment of Botulinum Toxin A for Pain Treatment in a Private Outpatient Setting
- 16 January 2001
- journal article
- Published by The Haworth Press in Journal of Musculoskeletal Pain
- Vol. 9 (1) , 67-82
- https://doi.org/10.1300/j094v09n01_08
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Mechanism of botulinum toxin in the relief of chronic painCurrent Review of Pain, 1999
- Development of the Neck Pain and Disability ScaleSpine, 1999
- A Randomized, Double-Blind, Prospective Pilot Study of Botulinum Toxin Injection for Refractory, Unilateral, Cervicothoracic, Paraspinal, Myofascial Pain SyndromeSpine, 1998
- Botulinum Toxin A, Adjunctive Therapy for Refractory Headaches Associated With Pericranial Muscle TensionHeadache: The Journal of Head and Face Pain, 1998
- Botulinum Toxin Injection for Cervicogenic HeadacheHeadache: The Journal of Head and Face Pain, 1997
- Botulinum toxin in the treatment of myofascial pain syndromePain, 1994
- Tension Headache: Botulinum Toxin Paralysis of Temporal MusclesHeadache: The Journal of Head and Face Pain, 1994
- Treatment of Myofascial Pain with Botulinum A ToxinAnesthesiology, 1994
- Myofascial Trigger Points Show Spontaneous Needle EMG ActivitySpine, 1993
- Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasmMovement Disorders, 1987